A recent CNN article discussed drugmaker Johnson & Johnson’s decision to pause their COVID-19 vaccine trial. The announcement came last Monday, and is attributed to an unexplained illness in one of the volunteers. The company is unclear whether the patient received a placebo or the experimental vaccine, but that’s not uncommon in a large scale study like this, which involves 60,000 patients.
Johnson & Johnson Pauses COVID-19 Vaccine Trial
The temporary pause is due to an “unexplained illness” in one participant.
Oct 19, 2020
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Have You Heard About our Podcasts?
Through the Line podcasts explore innovations and information across the packaging and processing landscape. Join us for the latest insights, trends, and strategies shaping packaging and processing today.
Listen Today
Downloads
